Literature DB >> 9326340

Common BRCA1 variants and transcriptional activation.

A N Monteiro, A August, H Hanafusa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9326340      PMCID： PMC1715961          DOI： 10.1086/515515

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  9 in total

1.  Transcriptional activation by BRCA1.

Authors:  M S Chapman; I M Verma
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

2.  BRCA1 protein products ... Functional motifs...

Authors:  E V Koonin; S F Altschul; P Bork
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

3.  Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

Authors:  A M Dunning; M Chiano; N R Smith; J Dearden; M Gore; S Oakes; C Wilson; M Stratton; J Peto; D Easton; D Clayton; B A Ponder
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

4.  Association of BRCA1 with Rad51 in mitotic and meiotic cells.

Authors:  R Scully; J Chen; A Plug; Y Xiao; D Weaver; J Feunteun; T Ashley; D M Livingston
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

5.  Evidence for a transcriptional activation function of BRCA1 C-terminal region.

Authors:  A N Monteiro; A August; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

7.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome.

Authors:  S A Smith; D F Easton; D G Evans; B A Ponder
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

9.  Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.

Authors:  S L Neuhausen; C J Marshall
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701
  9 in total
  11 in total

Review 1.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

2.  Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

Authors:  Marcelo A Carvalho; Sylvia M Marsillac; Rachel Karchin; Siranoush Manoukian; Scott Grist; Ramona F Swaby; Turan P Urmenyi; Edson Rondinelli; Rosane Silva; Luis Gayol; Lisa Baumbach; Rebecca Sutphen; Jennifer L Pickard-Brzosowicz; Katherine L Nathanson; Andrej Sali; David Goldgar; Fergus J Couch; Paolo Radice; Alvaro N A Monteiro
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

3.  Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Authors:  J Vallon-Christersson; C Cayanan; K Haraldsson; N Loman; J T Bergthorsson; K Brøndum-Nielsen; A M Gerdes; P Møller; U Kristoffersson; H Olsson; A Borg; A N Monteiro
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

4.  BRCA1 regulates p53-dependent gene expression.

Authors:  T Ouchi; A N Monteiro; A August; S A Aaronson; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Classification of BRCA1 missense variants of unknown clinical significance.

Authors:  C M Phelan; V Dapic; B Tice; R Favis; E Kwan; F Barany; S Manoukian; P Radice; R B van der Luijt; B P M van Nesselrooij; G Chenevix-Trench; T Caldes; M de la Hoya; S Lindquist; S V Tavtigian; D Goldgar; A Borg; S A Narod; A N A Monteiro
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

6.  Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.

Authors:  F Hayes; C Cayanan; D Barillà; A N Monteiro
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

7.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

8.  Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.

Authors:  Marcelo Carvalho; Maria A Pino; Rachel Karchin; Jennifer Beddor; Martha Godinho-Netto; Rafael D Mesquita; Renato S Rodarte; Danielle C Vaz; Viviane A Monteiro; Siranoush Manoukian; Mara Colombo; Carla B Ripamonti; Richard Rosenquist; Graeme Suthers; Ake Borg; Paolo Radice; Scott A Grist; Alvaro N A Monteiro; Blase Billack
Journal:  Mutat Res       Date:  2008-10-17       Impact factor: 2.433

9.  Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.

Authors:  Sunita Saxena; Anurupa Chakraborty; Mishi Kaushal; Sanjeev Kotwal; Dinesh Bhatanager; Ravindar S Mohil; Chintamani Chintamani; Anil K Aggarwal; Veena K Sharma; Prakash C Sharma; Gilbert Lenoir; David E Goldgar; Csilla I Szabo
Journal:  BMC Med Genet       Date:  2006-10-04       Impact factor: 2.103

10.  BRCA1 and BRCA2 germline mutation analysis in the Indonesian population.

Authors:  Dewajani Purnomosari; Gerard Pals; Artanto Wahyono; Teguh Aryandono; Tjakra W Manuaba; Samuel J Haryono; Paul J van Diest
Journal:  Breast Cancer Res Treat       Date:  2007-02-15       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.